Keith A. Kucinski, Chief Financial Officer at Matinas BioPharma Holdings, Inc. (MTNB), bought 94,500 shares at $1.23 ($115K) on 2019-11-25, disclosed to the SEC on 2019-11-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.20 | 36,500 | $44K | 38.0% |
| 2 | $1.23 | 58,000 | $71K | 62.0% |
| Total | $1.22 avg | 94,500 | $115K | 100% |